Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

Virtual Screening for New GABA Transporter 1 Inhibitors Based on Insights Acquired by Comparative Modeling

Andreas Jurik , Barbara Zdrazil , Harald H. Sitte , Gerhard Ecker
245th National Spring Meeting of the American-Chemical-Society (ACS)
Conference, Poster presentation
..2013 - ..2013

The medicinal chemistry of drug transport – knowledge based ligand design.

Gerhard Ecker
3rd Portuguese Meeting on Medicinal Chemistry
Conference, Talk or oral contribution
28.11.2012 - 28.11.2012

Ligand efficiency and lipophilic efficiency – versatile parameters for the design of inhibitors of transmembrane transporters?

Gerhard Ecker
5th Annual SFB35 Symposium "Transmembrane Transporters in Health and Disease"
Conference, Talk or oral contribution
24.9.2012 - 24.9.2012

The molecular basis of drug-transporter interaction - science or fiction?

Gerhard Ecker
42nd Annual Drug Metabolism Gordon Research Conference
Conference, Talk or oral contribution
12.7.2012 - 12.7.2012

Arzneistofftransporter und ihre Rolle in der Pharmaforschung

Gerhard Ecker
Talk or oral contribution
21.6.2012 - 21.6.2012